Amgen CFO logs tax-share withholding on equity

Amgen Inc. EVP & CFO Peter H. Griffith reported two tax-related share dispositions of company common stock.

Rhea-AI Filing Summary

Amgen Inc. EVP & CFO Peter H. Griffith reported two tax-related share dispositions of company common stock. On May 2, 2026, he delivered 687 shares and 746 shares of Amgen stock at $329.82 per share each as tax-withholding transactions, not open-market sales.

After these dispositions, his reported direct holdings in Amgen common stock were 47,568 shares following one transaction and 48,255 shares following the other. A footnote notes that his holdings include 454 Dividend Equivalents tied to unvested Restricted Stock Units under Amgen’s equity incentive plan, which pay out in shares as the awards vest.

Insider Trade Summary

Exercise Price or Tax Liability: 1,433 shares

Exercise Price or Tax Liability 2 txns

Insider Griffith Peter H.

Role EVP & CFO

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	746	$329.82	$246K
Exercise Price or Tax Liability	Common Stock	687	$329.82	$227K

Holdings After Transaction: Common Stock — 47,568 shares (Direct)

Footnotes (1)

1. F1. These shares include 454 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

Key Figures

Tax-withholding shares: 1,433 shares First tax-withholding lot: 687 shares at $329.82/share Second tax-withholding lot: 746 shares at $329.82/share +3 more

6 metrics

Tax-withholding shares 1,433 shares Total F-code tax-withholding dispositions on May 2, 2026

First tax-withholding lot 687 shares at $329.82/share Common Stock delivered for tax liability on May 2, 2026

Second tax-withholding lot 746 shares at $329.82/share Common Stock delivered for tax liability on May 2, 2026

Holdings after transaction 48,255 shares Direct Amgen common stock holdings after one F-code transaction

Holdings after transaction 47,568 shares Direct Amgen common stock holdings after the other F-code transaction

Dividend Equivalents credited 454 DEs Dividend Equivalents tied to unvested RSUs under 2009 Equity Incentive Plan

Key Terms

Dividend Equivalents (DEs), Restricted Stock Units, Equity Incentive Plan

3 terms

Dividend Equivalents (DEs) financial

"These shares include 454 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

Restricted Stock Units financial

"DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Equity Incentive Plan financial

"granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan"

An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Amgen (AMGN) report for CFO Peter H. Griffith?

Amgen reported that EVP & CFO Peter H. Griffith delivered company shares to cover tax obligations. He disposed of a total of 1,433 common shares through tax-withholding transactions rather than open-market sales, reflecting routine administration of equity compensation rather than discretionary trading.

How many Amgen shares were used for tax withholding in this Form 4?

The Form 4 shows 1,433 Amgen common shares delivered for tax withholding. This came from two transactions of 687 shares and 746 shares each, both priced at $329.82 per share, to satisfy tax liabilities tied to equity compensation awards vesting.

Did Amgen CFO Peter H. Griffith sell shares on the open market?

The transactions were coded as “F,” indicating tax-withholding dispositions, not open-market sales. Shares were delivered back to Amgen to pay exercise price or tax liabilities associated with equity awards, a common administrative step in stock-based compensation programs.

How many Amgen shares does the CFO hold after these tax-withholding transactions?

The Form 4 shows Griffith’s direct Amgen holdings at 48,255 shares after one tax-withholding transaction and 47,568 shares after the other. These figures indicate he continues to hold a substantial equity position in the company following routine tax-related dispositions.

What are Dividend Equivalents (DEs) mentioned in Amgen CFO’s Form 4?

Dividend Equivalents in this filing are credits tied to unvested Restricted Stock Units under Amgen’s equity incentive plan. The footnote states 454 DEs are credited and will pay out in Amgen common stock on a one-to-one basis as the underlying RSUs vest, plus cash for fractional amounts.

Which Amgen equity plan governs the CFO’s Dividend Equivalents and RSUs?

The filing states the Dividend Equivalents were granted under the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan. Under this plan, Dividend Equivalents are credited to unvested Restricted Stock Units and paid in Amgen common stock as the awards follow their vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 08:08 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Griffith Peter H.

(Last) (First) (Middle)

ONE AMGEN CENTER DRIVE

(Street)

THOUSAND OAKS CALIFORNIA 91320

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AMGEN INC [ AMGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & CFO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/02/2026		F		746	D	$329.82	48,255	D
Common Stock	05/02/2026		F		687	D	$329.82	47,568(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares include 454 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

	/s/ Peter H. Griffith	05/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)